MICHAEL VASCONCELLES

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Charles N. York II, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by MICHAEL VASCONCELLES:

Company Role Class Num Shares Value Price $ Report Date Ownership
ImmunoGen, Inc. EVP R&D & MEDICAL AFFAIRS Common Stock 0 $0 $29.30 12 Feb 2024 Direct
ImmunoGen, Inc. EVP R&D & MEDICAL AFFAIRS Restricted Stock Unit 0 $0 $29.30 12 Feb 2024 Direct
ImmunoGen, Inc. EVP R&D & MEDICAL AFFAIRS Stock Option (Right to Buy) 0 $0 $4.56 12 Feb 2024 Direct
Day One Biopharmaceuticals, Inc. Head of Research and Dev. Restricted Stock Unit (RSU) 226,000 16 Jun 2025 Direct
Day One Biopharmaceuticals, Inc. Head of Research and Dev. Stock Option (right to buy Common Stock) 171,000 30 Jan 2026 Direct
Day One Biopharmaceuticals, Inc. Head of Research and Dev. Restricted Stock Units 114,000 30 Jan 2026 Direct
Magenta Therapeutics, Inc. Director Stock Option (Right to Buy) 40,000 15 Aug 2022 Direct
Kura Oncology, Inc. Director Option to purchase common stock 28,500 05 Jun 2025 Direct

Insider Reports Filed by MICHAEL VASCONCELLES

Symbol Company Period Transactions Value $ Form Type Role Filing Time
DAWN Day One Biopharmaceuticals, Inc. 30 Jan 2026 2 $0 4 Head of Research and Dev. 30 Jan 2026, 17:18
DAWN Day One Biopharmaceuticals, Inc. 16 Jun 2025 2 $0 4 Head of Research and Dev. 18 Jun 2025, 19:42
DAWN Day One Biopharmaceuticals, Inc. 16 Jun 2025 0 $0 3 Head of Research and Dev. 18 Jun 2025, 19:41
KURA Kura Oncology, Inc. 05 Jun 2025 1 $0 4 Director 06 Jun 2025, 16:05
KURA Kura Oncology, Inc. 13 Sep 2024 0 $0 3 Director 17 Sep 2024, 16:10
KURA Kura Oncology, Inc. 13 Sep 2024 2 $0 4 Director 17 Sep 2024, 16:10
/report/000110465924014692-vasconcelles-michael-2024-02-12 ImmunoGen, Inc. 12 Feb 2024 3 $0 4 EVP R&D & MEDICAL AFFAIRS 12 Feb 2024, 16:35
/report/000141588924002764-vasconcelles-michael-2024-02-01 ImmunoGen, Inc. 01 Feb 2024 1 $0 4 EVP R&D & MEDICAL AFFAIRS 05 Feb 2024, 21:29
/report/000141588924000380-vasconcelles-michael-2023-12-29 ImmunoGen, Inc. 29 Dec 2023 1 +$21,245 4 EVP R&D & MEDICAL AFFAIRS 03 Jan 2024, 17:48
/report/000141588923000099-vasconcelles-michael-2022-12-29 ImmunoGen, Inc. 29 Dec 2022 1 $0 4 EVP R&D & MEDICAL AFFAIRS 03 Jan 2023, 16:17
/report/000141588923000097-vasconcelles-michael-2022-12-29 ImmunoGen, Inc. 29 Dec 2022 0 $0 3 EVP R&D & MEDICAL AFFAIRS 03 Jan 2023, 16:15
DNTH Magenta Therapeutics, Inc. 15 Aug 2022 1 $0 4 Director 17 Aug 2022, 08:19
DNTH Magenta Therapeutics, Inc. 15 Aug 2022 0 $0 3 Director 17 Aug 2022, 08:16